Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic angiogenesis profiling for first-line chemotherapy in patients with advanced gastric cancer.

Cancer investigation - 1 Jul 2013

Dan Su, Bai Li, Li-Jie Wang, Ting Zhang, Zhi-Yuan Mao

Abstract excerpt

We retrospectively investigated germline polymorphisms in angiogenesis pathway genes (14 SNPs) and their correlation to clinical outcome (progression free survival and overall survival) in 128 patients with unresectable-advanced gastric carcinoma (AGC) treated with first-line chemotherapy. Our analysis revealed that Endostatin +4349 G>A polymorphism exhibited a worse progression free survival (PFS) and overall...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Disease-Free Survival
Share to Genetic Association Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Induction Chemotherapy

Share to Multivariate Analysis

Share to Neovascularization, Pathologic

Share to Nitric Oxide Synthase Type III

Share to Stomach Neoplasms

Source

Identifiers

PMID: 23641912
DOI: 10.3109/07357907.2013.795580

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic angiogenesis profiling for first-line chemotherapy in patients with advanced gastric cancer.PMID 23641912Read ↗

Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients.Semantic proximity Read ↗

Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric CancerSemantic proximity Read ↗

Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.Semantic proximity Read ↗

Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer.Semantic proximity Read ↗

Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival.Semantic proximity Read ↗

Development of a novel angiogenesis-associated gene model for prognosis prediction in colorectal cancer.Semantic proximity Read ↗

An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.Semantic proximity Read ↗

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.Semantic proximity Read ↗

Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.Semantic proximity Read ↗

Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib.Semantic proximity Read ↗

Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer.Semantic proximity Read ↗

Polymorphisms in the Angiogenesis-Related Genes EFNB2, MMP2 and JAG1 Are Associated with Survival of Colorectal Cancer Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.